Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy

An announcement from Ampio Pharmaceuticals (AMPE) is now available.

Ampio Pharmaceuticals, Inc. has announced the termination of its at-the-market equity distribution agreement with H.C. Wainwright & Co., LLC, effective March 6, 2024. This agreement, initiated on September 18, 2023, was for the periodic sale of the company’s common stock. Following the termination, Ampio Pharmaceuticals has also filed to withdraw any unsold or unissued securities under its current registration, signaling a significant shift in its stock offering strategy.

See more insights into AMPE stock on TipRanks’ Stock Analysis page.